Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

CSF beta-EP in headache and depression.

G Nappi, F Facchinetti, E Martignoni

    Cephalalgia : an International Journal of Headache
    |June 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    p53 status is neither a predictive nor a prognostic variable in patients with advanced ovarian cancer treated with a paclitaxel-based regimen.

    Anticancer research·2001
    Same author

    Serum allopregnanolone in women with postpartum "blues".

    Obstetrics and gynecology·2001
    Same author

    The use of a starting dose of recombinant follicle stimulating hormone for controlled ovarian hyperstimulation: a randomized pilot study.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
    Same author

    Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
    Same author

    Ovarian follicular fluid contains immunoreactive estriol: lack of correlation with estradiol concentrations.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
    Same author

    Dose-response efficacy of a new estradiol transdermal matrix patch for 7-day application: a randomized, double-blind, placebo-controlled study. Italian Menopause Research Group.

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2000
    Same journal

    Cerebrovascular risk with calcitonin gene-related peptide monoclonal antibodies versus onabotulinumtoxinA in patients with migraine: A real-world pharmacoepidemiologic study in the National Institutes of Health All of Us Research Program.

    Cephalalgia : an international journal of headache·2026
    Same journal

    Burning mouth syndrome and oral dysaesthetic/perceptual symptoms: Toward clinically actionable boundaries.

    Cephalalgia : an international journal of headache·2026
    Same journal

    Effectiveness and clinical predictors of rimegepant for acute vertigo in vestibular migraine: A real-world cohort study.

    Cephalalgia : an international journal of headache·2026
    Same journal

    Efficacy of digital therapeutic sinCephalea for personalised nutrition versus control for migraine prevention: A 12-week open-label randomised clinical trial.

    Cephalalgia : an international journal of headache·2026
    Same journal

    SafeTy and effectiveness of Atogepant accoRding to the IHS outcome categories: A multicentric, prospective observational study in real life (the 24-week STAR study).

    Cephalalgia : an international journal of headache·2026
    Same journal

    Placebo or active comparator in chronic migraine trials: Balancing evidence and practicality.

    Cephalalgia : an international journal of headache·2026
    See all related articles

    Cerebrospinal fluid beta-endorphin (beta-EP) is significantly reduced in migraineurs, suggesting a role in chronic pain. This reduction is also observed in depressed patients with coexisting headaches.

    Area of Science:

    • Neuroscience
    • Biochemistry

    Background:

    • Beta-endorphin (beta-EP) is a neuropeptide involved in pain modulation.
    • Migraine and major depression are complex conditions with overlapping pathophysiology.
    • Previous research suggests altered neuropeptide levels in these disorders.

    Purpose of the Study:

    • To investigate cerebrospinal fluid (CSF) beta-endorphin levels in migraineurs with interparoxysmal headache (MIH).
    • To compare CSF beta-EP levels between patients with major depression, MIH, and healthy controls.
    • To explore the relationship between CSF beta-EP and coexisting headache and depression.

    Main Methods:

    • Measurement of beta-EP in CSF using radioimmunoassay (RIA) after gel-chromatography.
    • Comparison of beta-EP levels across three groups: MIH patients, depressed patients (with and without MIH), and age-matched controls.

    Related Experiment Videos

  • Statistical analysis to determine significant differences in beta-EP concentrations.

    • Main Results:

    • CSF beta-EP levels were significantly lower in migraineurs (15.0 +/- 11.1 fmol/ml) compared to controls (65.8 +/- 26.6 fmol/ml).
    • Depressed patients showed beta-EP levels (58.5 +/- 21.0 fmol/ml) similar to controls.
    • Depressed patients with coexisting MIH had reduced beta-EP levels (22.8 +/- 7.2 fmol/ml) compared to depressed patients without pain.

    Conclusions:

    • Reduced CSF beta-EP levels are associated with migraine, independent of affective state.
    • The findings suggest beta-EP plays a role in chronic pain mechanisms.
    • Coexistence of headache and depression may further impact beta-EP levels, highlighting its involvement in complex pain conditions.